News

Pfizer and BioNTech have started a mid-stage trial of a new version of the COVID-19 vaccine based on a version of the spike protein that they hope will offer greater and broader protection against ...
Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...
Pfizer and BioNTech have announced ... monovalent – containing or encoding the spike protein of only the Original SARS-CoV-2 virus – COVID-19 vaccine or receipt of the most recent booster ...
The vaccine is the only protein-based COVID shot still in use in the U.S. This approval would allow the vaccine to stay on ...